$88M sweet spot round size
Most of their 5 investments are in rounds between $20M and $100M
2010
Immatics Biotechnologies raised undisclosed on September 11, 2023
Investors: Moderna
Generation Bio raised $76M on March 23, 2023
Investors: Moderna
Metagenomi raised $100M on January 5, 2023
Investors: Novo Holdings, Leaps by Bayer, Catalio Capital Management and Moderna
Metagenomi raised $175M on January 25, 2022
Investors: Partner Fund Management, Pura Vida Investments, Millennium Partners, Surveyor Capital, YAYA Capital, Novo Holdings, Leaps by Bayer, Marshall Wace, RA Capital Management, L.P. and Moderna
Onkaido Therapeutics raised $20M on January 14, 2014
Investors: Moderna
$500M
from 18 investors over 18 rounds
Moderna raised $250M on October 12, 2022
Investors: MSD Capital
Moderna raised $472M on July 26, 2020
Investors: Biomedical Advanced Research and Development Authority (BARDA)
Moderna raised $483M on April 17, 2020
Investors: Biomedical Advanced Research and Development Authority (BARDA)
Moderna raised $125M on May 3, 2018
Investors: Merck Group
Moderna raised $500M on February 1, 2018
Investors: Sequoia Capital China, Julius Baer, Abu Dhabi Investment Authority (ADIA), EDBI Pte Ltd, Viking Global Investors and Pictet Asset Management
Moderna raised $8M on September 7, 2016
Investors: Biomedical Advanced Research and Development Authority (BARDA)
Moderna raised $20M on January 12, 2016
Investors: Bill & Melinda Gates Foundation
Moderna raised $450M on January 5, 2015
Investors: Viking Global Investors, The Invus Group, RA Capital Management, L.P., Alexion Pharmaceuticals, Inc. and Wellington Management
Moderna raised $25M on January 14, 2014
Investors: Alexion Pharmaceuticals, Inc.